Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis
- PMID: 25688507
- DOI: 10.1700/1778.19288
Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis
Abstract
Background and objectives: The rapid development of the Chinese economy has enabled advances to be made in the surgical treatment of Klatskin tumors. We retrospectively reviewed the surgical outcomes of hilar cholangiocarcinoma at a single Chinese center, focusing on the surgical procedures, radicality of the operative procedure (R0, R1 or R2), survival rates, and independent prognostic factors. This objective of the analysis was to evaluate improvements in perioperative and long-term outcomes of surgical resection of Klatskin tumors.
Methods: Between January 1998 and December 2007, 131 consecutive patients underwent operative resection for Klatskin tumor at Tianjin Medical University General Hospital, Tianjin, China. Clinicopathological data were analyzed to assess their impact on survival.
Results: The overall 3- and 5-year survival rates were 46% and 22%, respectively. Median overall survival for the entire cohort was 35 months. Survival increased progressively between 1998 and 2007. Preoperative biliary drainage represents a safe strategy before hepatectomy for hilar cholangiocarcinoma in patients with jaundice. Patients who underwent liver resection achieved significantly higher R0 rates than those undergoing biliary resection only. Preoperative total bilirubin level, lymph node metastasis and degree of radicality (R1 and 2 vs R0) were found to be independent factors that negatively affected overall survival.
Conclusions: Surgical resection remains the mainstay of treatment for hilar cholangiocarcinoma. Development in surgical equipment, techniques, and perioperative management have increased long-term survival after curative liver resection, despite the more aggressive surgical procedures that are being performed.
Similar articles
-
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11. Eur J Surg Oncol. 2019. PMID: 31208772
-
[Surgical therapy of hilar cholangiocarcinoma].Chirurg. 2006 Apr;77(4):325-34. doi: 10.1007/s00104-006-1177-4. Chirurg. 2006. PMID: 16568258 German.
-
[Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].Zhonghua Wai Ke Za Zhi. 2024 Apr 1;62(4):290-301. doi: 10.3760/cma.j.cn112139-20231221-00296. Zhonghua Wai Ke Za Zhi. 2024. PMID: 38432670 Chinese.
-
[Klatskin tumor. A study of 15 resected cases].Chirurgie. 1999 Apr;124(2):132-9; discussion 139-40. doi: 10.1016/s0001-4001(99)80055-5. Chirurgie. 1999. PMID: 10349749 Review. French.
-
Liver transplantation for hilar cholangiocarcinoma.World J Gastroenterol. 2013 Dec 28;19(48):9209-15. doi: 10.3748/wjg.v19.i48.9209. World J Gastroenterol. 2013. PMID: 24409049 Free PMC article. Review.
Cited by
-
Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies.Ther Adv Gastrointest Endosc. 2021 Feb 10;14:2631774521993065. doi: 10.1177/2631774521993065. eCollection 2021 Jan-Dec. Ther Adv Gastrointest Endosc. 2021. PMID: 33629062 Free PMC article.
-
Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis.Biomed Res Int. 2018 Jan 8;2018:3812424. doi: 10.1155/2018/3812424. eCollection 2018. Biomed Res Int. 2018. PMID: 29511679 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical